SigmaRoc H1 2026 slides: EBITDA up 11%, strategic dolime acquisition

SigmaRoc reported H1 2026 revenue of £523.1 million, up 2.5% year over year, while EBITDA rose 11.3% to £131.2 million and margin expanded 200bps to 25.1%; EPS increased 12.2% to 5.23p. The company announced the €110 million acquisition of Lithuanian dolomitic limestone producer Dolomitas at 6.0x EBITDA, expected to be immediately earnings-enhancing from 2027 and to expand its exposure to European green-steel demand. Net leverage improved to 1.66x from 1.8x at year-end 2025, while management maintained full-year consensus expectations of £1.066 billion revenue and £276 million underlying EBITDA.

Analysis

The investable implication is less the reported beat than whether SigmaRoc can convert a self-help-heavy earnings base into durable organic pricing power. The haulage change and exited low-margin contracts create a difficult H2/H1 comparison, so the market should not capitalize the latest margin run-rate as entirely recurring; a normalization in incremental margins would matter more than another modest revenue beat. The key read-through for CRH is limited: SigmaRoc's higher-value lime/dolime mix is more insulated from conventional aggregates cyclicality, while its expansion reinforces the premium being placed on permitted, long-life mineral reserves near industrial demand.

Dolomitas is strategically attractive only if announced EAF/DRI projects become operating plants on schedule. European green-steel timelines remain vulnerable to power-price volatility, permitting, subsidy disbursement and weak regional steel demand; delays would defer volume growth while acquisition leverage and integration costs arrive immediately. Near term, regulatory clearance, Belgian plant commissioning and the first post-close synergy/volume disclosure are the relevant catalysts; over 6-18 months, contract wins tied to operating steel capacity—not project announcements—will determine whether the acquisition deserves a rerating.

The article's price and ticker presentation require verification before trading: SigmaRoc is a London-listed small/mid-cap name, and the quoted dollar price appears inconsistent with the stated pence-based transaction reference. Liquidity, free float, current EV/EBITDA and pro-forma net leverage after the acquisition are missing, making a directional recommendation premature despite favorable operating momentum. Consensus may be underestimating the scarcity value of permitted dolomite reserves, but it may also be over-crediting a green-steel demand curve that remains largely policy-dependent rather than contracted.

Key Decisions for Investors

• Place SRC.L on a post-results watchlist rather than chase the initial move; initiate only after confirming current valuation, average daily liquidity, regulatory status and pro-forma leverage. Preferred trigger: shares retrace 5-10% without a cut to EBITDA guidance, or management demonstrates that margin gains excluding haulage/accounting effects remain intact.
• If verified EV/EBITDA remains at a material discount to specialty-minerals peers after including Dolomitas, build a 6-12 month long SRC.L position ahead of Q4 closing and Belgian ramp-up. Size modestly given small-cap liquidity; thesis is invalidated by clearance failure, pro-forma leverage above the stated operating range, or a material reduction in 2027 earnings accretion guidance.
• Use CRH as a relative hedge only if European construction indicators deteriorate: long SRC.L / short CRH can isolate specialty industrial-minerals exposure from broad construction demand, but avoid the pair if SRC.L's valuation premium exceeds its demonstrated returns improvement. Reassess after the next European steel production and construction PMI releases.
• Monitor European EAF/DRI final-investment decisions, power-price spreads and steel utilization over the next 3-6 months. Treat customer contracts or binding offtake linked to operating green-steel assets as a buy catalyst; treat project cancellations, subsidy delays or declining steel output as a signal to reduce exposure.